Feb 11 2010
SafeBridge® Consultants, Inc. (“SafeBridge”) headquartered in
Mountain View, California announced today that its industrial hygiene
analytical laboratory has recently validated an industrial hygiene air
sampling and analytical method with improved analytical sensitivity for
measurement of naproxen sodium on filters. SafeBridge now has a
validated method that will detect as low as 20 picograms per filter in
an air sample collected on appropriate media. This limit of detection is
four (4) to five (5) times lower than methods available from other
commercial laboratories.
President and CEO John Farris commented, “Naproxen sodium can now be
measured at lower concentrations in air which creates an effective tool
for organizations involved in handling hazardous materials in powder and
liquid forms. This is important to pharmaceutical and chemical companies
as well as containment and engineering control vendors. Industrial
hygiene studies using sensitive methods can predict potential worker
exposures and identify sources of emissions for the purpose of
preventing occupational disease. Our chemists have done excellent and
scientifically supportable work to meet our customer needs”.
SafeBridge’s industrial hygiene laboratory is accredited by the American
Industrial Hygiene Association (AIHA) for the analysis of active
pharmaceutical ingredients. The SafeBridge advantage is the application
of the most sensitive techniques in the industry to detect potent drugs
at very low concentrations in the workplace. The laboratory routinely
develops methods and analyzes samples that contain biologically active
pharmaceuticals such as steroid hormones, enzymes, peptide hormones,
antibody drug conjugates (ADCs) and “cytotoxic” compounds. The
SafeBridge laboratory is especially knowledgeable in the development of
immunoassays and application of ELISA technology to detect low
concentrations of highly potent drugs on filters.
Source SAFEBRIDGE CONSULTANTS, INC.
International collaboration reveals alarming rise in global obesity